Role of Rebiopsy in Relapsed Non-Small Cell Lung Cancer for Directing Oncology Treatments

Table 4

Rebiopsy and lung cancer.

	Number of articles	Number of patients	Content	Reference
Case reports	4	8		[17–20]
Pharmacoeconomic analysis	1			[16]
Original articles	9
		53	TS expression	[9]
		65	Beta tubulin	[8]
		70	T790 mutation	[15]
		78	T790 mutation	[14]
		93	T790 mutation	[13]
		94	EGFR mutations; ALK rearrangement	[12]
		121	T790 mutation	[11]
		155	Mutation genotyping	[10]
		331	ECCI and RRMI proteins	[7]